Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerstein

Showing results (1251-1260 of 1,597) with videos related to

Pageof 160
Sort By:
The Lancet. Child & Adolescent Health|January 9, 2026
Delayed puberty and early-onset type 2 diabetes risk: a nationwide cohort study of male adolescents in IsraelOrit Pinhas-Hamiel, Maya Simchoni, Estela Derazne, et al.
The Lancet Regional Health. Europe|May 28, 2024
Non-coronary peripheral arterial complications in people with type 2 diabetes: a Swedish retrospective cohort studyAraz Rawshani, Björn Eliasson, Jan Boren, et al.
Lancet (London, England)|August 18, 2009
Albuminuria in chronic heart failure: prevalence and prognostic importanceColette E Jackson, Scott D Solomon, Hertzel C Gerstein, et al.
Cold Spring Harbor Symposia on Quantitative Biology|March 27, 2007
Novel transcribed regions in the human genomeJ Rozowsky, J Wu, Z Lian, et al.
The American Journal of Cardiology|July 12, 2007
Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trialDavid C Goff, Hertzel C Gerstein, Henry N Ginsberg, et al.
The Lancet Regional Health. Europe|May 28, 2024
Non-coronary arterial outcomes in people with type 1 diabetes mellitus: a Swedish retrospective cohort studyTarik Avdic, Björn Eliasson, Araz Rawshani, et al.
Nature Microbiology|May 11, 2026
Pooled CRISPRi screening reveals fungal-specific drug target candidatesLauren F Wensing, Philippe C Després, Desiree Francis, et al.
Diabetes, Obesity & Metabolism|July 2, 2026
Potential Mediators of Efpeglenatide's Cardiovascular Benefit: An Exploratory Analysis of the AMPLITUDE-O TrialDaniel Raaschou-Oddershede, Christine R Schwarz, Tanya Kovalova, et al.
Diabetes Care|January 28, 2009
Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trialTali Cukierman-Yaffe, Hertzel C Gerstein, Jeff D Williamson, et al.
The Journal of Clinical Endocrinology and Metabolism|February 4, 2021
Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trialMatthew C Riddle, Hertzel C Gerstein, Denis Xavier, et al.
Pageof 160

Showing results (1251-1260 of 1,597) with videos related to

Sort By:
Pageof 160
The Lancet. Child & Adolescent Health|January 9, 2026
Delayed puberty and early-onset type 2 diabetes risk: a nationwide cohort study of male adolescents in IsraelOrit Pinhas-Hamiel, Maya Simchoni, Estela Derazne, et al.
The Lancet Regional Health. Europe|May 28, 2024
Non-coronary peripheral arterial complications in people with type 2 diabetes: a Swedish retrospective cohort studyAraz Rawshani, Björn Eliasson, Jan Boren, et al.
Lancet (London, England)|August 18, 2009
Albuminuria in chronic heart failure: prevalence and prognostic importanceColette E Jackson, Scott D Solomon, Hertzel C Gerstein, et al.
Cold Spring Harbor Symposia on Quantitative Biology|March 27, 2007
Novel transcribed regions in the human genomeJ Rozowsky, J Wu, Z Lian, et al.
The American Journal of Cardiology|July 12, 2007
Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trialDavid C Goff, Hertzel C Gerstein, Henry N Ginsberg, et al.
The Lancet Regional Health. Europe|May 28, 2024
Non-coronary arterial outcomes in people with type 1 diabetes mellitus: a Swedish retrospective cohort studyTarik Avdic, Björn Eliasson, Araz Rawshani, et al.
Nature Microbiology|May 11, 2026
Pooled CRISPRi screening reveals fungal-specific drug target candidatesLauren F Wensing, Philippe C Després, Desiree Francis, et al.
Diabetes, Obesity & Metabolism|July 2, 2026
Potential Mediators of Efpeglenatide's Cardiovascular Benefit: An Exploratory Analysis of the AMPLITUDE-O TrialDaniel Raaschou-Oddershede, Christine R Schwarz, Tanya Kovalova, et al.
Diabetes Care|January 28, 2009
Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trialTali Cukierman-Yaffe, Hertzel C Gerstein, Jeff D Williamson, et al.
The Journal of Clinical Endocrinology and Metabolism|February 4, 2021
Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trialMatthew C Riddle, Hertzel C Gerstein, Denis Xavier, et al.
Pageof 160